retatrutide ly3437943 glp-1 gip glucagon LY3437943, a novel triple glucagon, GIP, and receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism Retatrutide 40mg (R&D Only) |

As the image below shows, fat consumption has steadily risen over the last century since we discovered how to extract oil from crops at scale, fuelled by synthetic fertilisers

Thus, although much research is focused on defining the direct intrakidney effects of GLP-1 receptor agonists, it is possible that some of the benefits occur indirectly, as a result of GLP-1 receptor agonists ability to improve kidney risk factors, as well as via extrarenal systemic effects of these agents that are not yet fully defined, such as attenuation of low-grade systemic inflammation

Understanding what to do when tirzepatide stops working or why you might not lose weight in the first four weeks on semaglutide can help determine whether a switch is truly needed or whether adjustments to the current medication might solve the problem

Cons of Lifestyle Programs: Modest weight loss results and high dependence on personal discipline

Benefits of GLP-1 use in children and adolescents Wegovy offers significant benefits for teens with obesity, including a 16% drop in BMI and improvements in metabolic health, which may lower long-term disease risk, says Dr